Hillegass L M, Griswold D E, Brickson B, Albrightson-Winslow C
Department of Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, PA 19406.
J Pharmacol Methods. 1990 Dec;24(4):285-95. doi: 10.1016/0160-5402(90)90013-b.
A method to quantitate myeloperoxidase (MPO) activity from rat whole kidney is described. Polymorphonuclear leukocyte (PMN) infiltration into tissue is a hallmark of acute inflammation. Historically, the degree of inflammation has been quantified by the identification and enumeration of PMNs histologically or by some other means. More recently, the enzyme activity of MPO, a marker enzyme for PMN, and freshly emigrated monocytes in many inflamed tissues has replaced these methods. The kidney, however, has been identified as a tissue from which MPO cannot be measured. Indeed, kidney homogenized by a standard extraction procedure was devoid of MPO activity. We modified the established methodology so that kidney was homogenized in 5 mM potassium phosphate buffer (PB) first and then centrifuged at 30,000 g for 30 min at 4 degrees C prior to extraction. The resulting 30,000 g pellets expressed MPO activity after suspending them in 50 mM PB containing 0.5% hexadecyltrimethylammoniumbromide (HTAB). Interference in the assay was observed with supernatants from control and inflamed kidney, which appeared to be due to kidney-derived material forming a complex with HTAB. After washing the pellets twice, we noted that their extracts exhibited greater activity, and interference from supernatants was abolished. Using this method, we observed that acutely inflamed kidneys from rats treated with sheep nephrotoxic immunoglobulin G (IgG) had significantly elevated MPO activity over kidneys from control rats. Thus, the described technique allows for the routine assay of MPO in kidney tissue.
本文描述了一种定量大鼠全肾髓过氧化物酶(MPO)活性的方法。多形核白细胞(PMN)浸润组织是急性炎症的一个标志。从历史上看,炎症程度是通过组织学上PMN的识别和计数或其他一些方法来量化的。最近,MPO(一种PMN的标志物酶)以及许多炎症组织中刚迁移过来的单核细胞的酶活性已经取代了这些方法。然而,肾脏已被确定为无法测量MPO的组织。事实上,通过标准提取程序匀浆的肾脏没有MPO活性。我们对既定方法进行了修改,使肾脏首先在5 mM磷酸钾缓冲液(PB)中匀浆,然后在4℃下以30,000 g离心30分钟,再进行提取。将所得的30,000 g沉淀悬浮于含有0.5%十六烷基三甲基溴化铵(HTAB)的50 mM PB中后,其表现出MPO活性。在对照和炎症肾脏的上清液中观察到了对测定的干扰,这似乎是由于肾脏来源的物质与HTAB形成了复合物。在将沉淀洗涤两次后,我们注意到它们的提取物表现出更高的活性,并且上清液的干扰被消除了。使用这种方法,我们观察到用羊肾毒性免疫球蛋白G(IgG)处理的大鼠的急性炎症肾脏的MPO活性比对照大鼠的肾脏显著升高。因此,所描述的技术允许对肾脏组织中的MPO进行常规测定。